首页> 外文期刊>Analytical chemistry >Magneto Immunoassays for Plasmodium falciparum Histidine-Rich Protein 2 Related to Malaria based on Magnetic Nanoparticles
【24h】

Magneto Immunoassays for Plasmodium falciparum Histidine-Rich Protein 2 Related to Malaria based on Magnetic Nanoparticles

机译:基于磁性纳米粒子的与疟疾相关的恶性疟原虫组氨酸-富集蛋白2的磁性免疫测定

获取原文
获取原文并翻译 | 示例
           

摘要

Magneto immunoassay-based strategies for the detection of Plasmodium falciparum histidine-rich protein 2 (HRP2) related to malaria are described for the first time by using magnetic micro- and nanoparticles. The covalent immobilization of a commercial monoclonal antibody toward the HRP2 protein in magnetic beads and nanoparticles was evaluated and compared. The immunological reaction for the protein HRP2 was successfully performed in a sandwich assay on magnetic micro- and nanoparticles by using a second monoclonal antibody labeled with the enzyme, horseradish peroxidase (HRP). Then, the modified magnetic particles were easily captured by a magneto sensor made of graphite-epoxy composite (m-GEC) which was also used as the transducer for the electrochemical detection. The performance of the immunoassay-based strategy with the electrochemical magneto immunosensors was successfully evaluated and compared with a novel magneto-ELISA based on optical detection using spiked serum samples. Improved sensitivity was obtained when using 300 nm magnetic nanoparticles in both cases. The electrochemical magneto immunosensor coupled with magnetic nanoparticles have shown better analytical performance in terms of limit of detection (0.36 ng mL~(-1)), which is much lower than the LOD reported by other methods. Moreover, at a low level of HRP2 concentration of 31.0 ng mL~(-1), a signal of 15.30 (mu)A was reached with a cutoff value of 0.34 (mu)A, giving a clear positive result with a non-specific adsorption ratio of 51. Due to the high sensitivity, this novel strategy offers great promise for rapid, simple, cost-effective, and on-site detection of falciparum malaria disease in patients, but also to screen out at-risk blood samples for prevention of transfusion-transmitted malaria.
机译:首次描述了基于磁性免疫测定的策略,用于检测与疟疾相关的恶性疟原虫组氨酸富集蛋白2(HRP2)。评估和比较了针对磁珠和纳米粒子中HRP2蛋白的商业单克隆抗体的共价固定。通过使用标记有辣根过氧化物酶(HRP)的第二种单克隆抗体,在磁性微颗粒和纳米颗粒的三明治试验中成功完成了蛋白HRP2的免疫反应。然后,通过由石墨-环氧复合材料(m-GEC)制成的磁传感器容易地捕获改性的磁性颗粒,该磁传感器也用作电化学检测的换能器。已成功评估了基于电化学磁免疫传感器的免疫测定策略的性能,并将其与基于基于加标血清样品的光学检测的新型磁ELISA进行了比较。在两种情况下都使用300 nm磁性纳米颗粒时,灵敏度得到了提高。电化学磁性免疫传感器与磁性纳米粒子的结合在检测限(0.36 ng mL〜(-1))方面表现出更好的分析性能,远低于其他方法报道的检测限。此外,在低水平的HRP2浓度为31.0 ng mL〜(-1)时,达到了15.30μA的信号,其截止值为0.34μA,给出了明显的阳性结果,且结果不明确吸附比为51。由于灵敏度高,这种新颖的方法为快速,简单,经济高效地就地检测患者的恶性疟疾提供了广阔的前景,而且还可以筛选出危险的血液样本进行预防输血传播的疟疾。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号